HIV: ART Therapy Medications and Classifications

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/13

flashcard set

Earn XP

Description and Tags

Vocabulary practice flashcards covering HIV antiretroviral therapy (ART) drug classifications, specific medications, dosing routes, schedules, and associated side effects.

14 Terms

1
New cards

Nucleoside Reverse Transcriptase Inhibitors (NRTI)

An antiretroviral therapy (ART) classification including Tenofovir and Zidovudine; side effects include headaches, weakness, N/V/D, liver & renal failure, lactic acidosis, rash, bone pain, lipodystrophy, seizure, and anxiety.

2
New cards

Tenofovir (Viread)

A Nucleoside Reverse Transcriptase Inhibitor (NRTI) administered orally once daily (PO daily).

3
New cards

Zidovudine (Retrovir)

A Nucleoside Reverse Transcriptase Inhibitor (NRTI) administered orally twice daily (PO BID).

4
New cards

Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI)

An ART drug classification associated with dizziness, fatigue, drowsiness, headaches, impaired concentration, insomnia, liver failure, N/V/D, rash, high cholesterol, and lipodystrophy; will develop resistance quickly if non-compliant with medication.

5
New cards

Nevirapine (Viramune)

A Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) administered orally twice daily (PO BID).

6
New cards

Efarvirenz (Sustiva)

A Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) administered orally once daily (PO daily).

7
New cards

Protease Inhibitors

An ART drug classification whose side effects include seizures, abnormal thoughts, weakness, dizziness, headache, pharyngitis, angioedema, heart block, orthostatic hypotension, N/V/D, constipation, renal insufficiency, rashes, sweating, hyperglycemia, hyperlipidemia, lipodystrophy, and paresthesia.

8
New cards

Ritonavir (Norvir)

A Protease Inhibitor antiretroviral medication administered orally twice daily (PO BID).

9
New cards

Fusion Inhibitors

An ART drug classification associated with side effects including injection site reactions, pneumonia, nerve joint muscle pain, insomnia, and depression.

10
New cards

Enfuvirtide (Fuzeon)

A Fusion Inhibitor antiretroviral medication administered subcutaneously twice daily (SQ BID).

11
New cards

Chemokine Coreceptor Antagonists (CCR5 antagonist)

An ART drug classification whose side effects include N/V/D, constipation, fatigue, dizziness, insomnia, cough, runny nose, rash, muscle joint pain, and liver failure.

12
New cards

Maraviroc (Selzentry)

A Chemokine Coreceptor Antagonist (CCR5 antagonist) administered orally twice daily (PO BID).

13
New cards

Integrase Inhibitors

An ART drug classification represented by Raltegravir (Isentress) taken PO BID; side effects include suicide, headache, depression, fatigue, dizziness, insomnia, MI, N/V/D, liver failure, gastritis, renal failure, anemia, rash, and lipodystrophy.

14
New cards

Bictegravir + Tenofovir Alafenamide + Emtricitabine (Biktarvy)

A combination antiretroviral medication administered orally once daily (PO daily); diarrhea, nausea, and headache are the most common side effects, alongside serious side effects listed in constituent classifications.